Coagulation Sciences LLC develops personalized medicine products and analytical instruments, specifically the Multiple Coagulation Test System, for hospitals and blood banks. The company's technology is designed to diagnose coagulation disorders, evaluate multiple treatment therapies, reduce unnecessary blood transfusions, and improve patient safety.
Subscribe to see Coagulation Sciences LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Coagulation Sciences LLC is a medical devices company headquartered in United States. Its most recent funding round raised $1.3M in March 2017. Xcout tracks 4 named people at Coagulation Sciences LLC, including Allen Goldman, BBA, MBA, CPA (Chief Financial Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.3M | — | |
| SEC Form D filing | $790,000 | — | |
| Seed | $1.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Coagulation Sciences LLC's closest competitors — see the full list of competitors and alternatives →
Stasys Medical Corp. is a medical device company co-founded in 2013, focusing on haemostasis monitoring solutions. Headquartered in Seattle, Washington, the company develops specialized diagnostic healthcare equipment.
HemoCue AB develops and manufactures point-of-care medical diagnostic systems and testing equipment. The company serves healthcare providers in clinical settings, hospitals, blood banks, and public health sectors by offering portable devices for hematology, diabetes management, and infection detection.
Accriva Diagnostics is a San Diego, California-based diagnostic company specializing in hemostasis, acute care diagnostics, and platelet reactivity testing. Formed by the 2013 merger of International Technidyne Corporation and Accumetrics, the company is now a part of Instrumentation Laboratory (Werfen).
Magnolia Medical Technologies develops medical devices, such as the Steripath platform, designed to reduce blood culture contamination and improve diagnostic accuracy for sepsis testing. The company serves hospitals, healthcare systems, and clinical professionals by providing solutions that support infection prevention and diagnostic stewardship.
Origin Sciences is a medical technology company based in the UK that develops innovative devices and tests to aid in the detection and diagnosis of gastrointestinal diseases.
Vail Scientific develops medical technology for the rapid, non-invasive, and real-time point-of-care detection of sepsis. The company provides healthcare providers with screening solutions utilizing proprietary nitric oxide technology to identify sepsis early and accelerate treatment.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.